Behar A, Maayan G
Chem Sci. 2024; .
PMID: 39464602
PMC: 11503657.
DOI: 10.1039/d4sc04313h.
Janse van Rensburg H, NDa D, Suganuma K
ACS Omega. 2023; 8(45):43088-43098.
PMID: 38024678
PMC: 10652724.
DOI: 10.1021/acsomega.3c06508.
Matta C
J Comput Chem. 2014; 35(16):1165-98.
PMID: 24777743
PMC: 4368384.
DOI: 10.1002/jcc.23608.
Fan X, Venegas R, Fey R, van der Heyde H, Bernard M, Lazarides E
Pharm Res. 2007; 24(5):868-79.
PMID: 17377744
DOI: 10.1007/s11095-007-9238-z.
Montanari C, Tute M, Beezer A, Mitchell J
J Comput Aided Mol Des. 1996; 10(1):67-73.
PMID: 8786416
DOI: 10.1007/BF00124466.
Time-independent effects on cardiac action potential upstroke velocity (resting block) and lipid solubility of beta adrenergic blockers.
Sada H, Ban T
Experientia. 1981; 37(2):171-2.
PMID: 6113159
DOI: 10.1007/BF01963214.
The selection of arylamidinourea antimalarials by their predicted physicochemical properties.
Cranfield R, Goodford P, Norrington F, Richards W, Sheppey G, Williams S
Br J Pharmacol. 1974; 52(1):87-92.
PMID: 4615765
PMC: 1776948.
DOI: 10.1111/j.1476-5381.1974.tb09690.x.
Relationships between chemical structure and affinity for postganglionic acetylcholine receptors of the guinea-pig ileum.
Abramson F, Barlow R, Franks F, Pearson J
Br J Pharmacol. 1974; 51(1):81-93.
PMID: 4441797
PMC: 1776805.
DOI: 10.1111/j.1476-5381.1974.tb09635.x.
The specificity of some agonists and antagonists for nicotine-sensitive receptors in ganglia.
Barlow R, Bowman F, Ison R, McQueen D
Br J Pharmacol. 1974; 51(4):585-97.
PMID: 4155978
PMC: 1778060.
DOI: 10.1111/j.1476-5381.1974.tb09678.x.
Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
Hellenbrecht D, Lemmer B, Wiethold G, Grobecker H
Naunyn Schmiedebergs Arch Pharmacol. 1973; 277(2):211-26.
PMID: 4145013
DOI: 10.1007/BF00501161.
Partitioning and lipophilicity in quantitative structure-activity relationships.
Dearden J
Environ Health Perspect. 1985; 61:203-28.
PMID: 3905374
PMC: 1568760.
DOI: 10.1289/ehp.8561203.
Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.
Goll A, Glossmann H, Mannhold R
Naunyn Schmiedebergs Arch Pharmacol. 1986; 334(3):303-12.
PMID: 3027587
DOI: 10.1007/BF00508786.
Structural factors in the in vivo chelate mobilization of aged cadmium deposits.
Singh P, Jones S, Jones M
Environ Health Perspect. 1990; 85:361-70.
PMID: 2384068
PMC: 1568338.
DOI: 10.1289/ehp.85-1568338.
Development of a preformulation lipophilicity screen utilizing a C-18-derivatized polystyrene-divinylbenzene high-performance liquid chromatographic (HPLC) column.
Lambert W, Wright L, Stevens J
Pharm Res. 1990; 7(6):577-86.
PMID: 2367326
DOI: 10.1023/a:1015857925630.
Structure-activity studies on nifedipine in isolated cardiac muscle.
Rodenkirchen R, Bayer R, Steiner R, Bossert F, Meyer H, Moller E
Naunyn Schmiedebergs Arch Pharmacol. 1979; 310(1):69-78.
PMID: 530314
DOI: 10.1007/BF00499876.
Inhibition of Bacillus subtilis spore germination by various hydrophobic compounds: demonstration of hydrophobic character of the L-alanine receptor site.
Hachisuka Y
J Bacteriol. 1978; 136(2):484-90.
PMID: 101524
PMC: 218570.
DOI: 10.1128/jb.136.2.484-490.1978.
